Skip to content

Author

Hyung-Don Kim

We have 2 of 110 papers

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Sep 2026

Effect of liver function on clinical outcomes in patients with unresectable hepatocellular carcinoma treated with first-line atezolizumab-bevacizumab: an Asia-Pacific multicenter retrospective analysis.

In multivariate analyses, CP class independently predicted PFS and OS, while ALBI predicted OS, which highlights the need to assess liver function when selecting systemic therapy and support further studies, including patients with impaired liver function.

Yeokyeong Shin, Young Jae Kim, D. Tai et al. · 0 citations
Oct 2026

ASTRUM-006 and the changing landscape of perioperative therapy for gastric cancer.

ASTRUM-006 provides phase 3 evidence that perioperative immune checkpoint inhibition improves event-free survival with Asian SOX-based chemotherapy in PD-L1-positive gastric cancer. Its postoperative chemotherapy-sparing strategy is attractive, although unmasking, event adjudication, and non-R0 or occult metastatic dis...

H. Kim, I. Chau, R. Sundar · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.